Clinical Trials at Providence Medical Foundation
As of August 2026, 28 paid clinical trials are recruiting at Providence Medical Foundation, located at 2141 N HARBOR BLVD STE 35000, FULLERTON, CA 92835, phone (714) 626-8630 in Fullerton, California. Active studies at this site cover conditions such as Advanced Solid Tumor, Carcinoma, Non-Small-Cell Lung and Breast Neoplasms. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Fullerton
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
29 clinical trials at Providence Medical Foundation
·Clear filters·A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Common conditions studied in Fullerton
- Advanced Solid Tumor (4 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Breast Neoplasms (3 active studies)
- Esophageal Squamous Cell Carcinoma (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Systemic Lupus Erythematosus (3 active studies)
Leading research sponsors in Fullerton
- Merck Sharp & Dohme LLC
- Amgen
- Janssen Research & Development, LLC
- TORL Biotherapeutics, LLC
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Fullerton?
There are approximately 96 recruiting clinical trials in Fullerton, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fullerton pay participants?
Most recruiting trials in Fullerton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fullerton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fullerton?
The most common conditions under active study in Fullerton include Advanced Solid Tumor (4), Carcinoma, Non-Small-Cell Lung (4), Breast Neoplasms (3), Esophageal Squamous Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fullerton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fullerton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fullerton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fullerton?
Recruiting research sites in Fullerton include Providence Medical Foundation, Providence St. Jude Medical Center, Retina Consultants of Orange County, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fullerton right now?
The largest active categories in Fullerton are Cancer & tumors (49), Eye & vision (9), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Providence Medical Foundation?
Providence Medical Foundation is located at 2141 N HARBOR BLVD STE 35000, FULLERTON, CA 92835. Use the Google Maps link in the intro above to get directions.
How do I contact Providence Medical Foundation?
You can reach Providence Medical Foundation by phone at (714) 626-8630. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.